Patent · US Active

Methods and compositions for detecting and treating drug resistant AKT mutant

US10612100B2 · kind B2 · utility

0Cited by
2References
8Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMay 8, 2018
Grant dateApr 7, 2020
Priority date
Expiry dateMay 8, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for identifying or diagnosing AKT inhibitor resistant cancers and methods an compositions for treating.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.